- Home
- INFU vs CTNM Comparison
INFU vs CTNM Comparison
Compare INFU & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- CTNM
- Stock Information
- Founded
- INFU 2005
- CTNM 2009
- Country
- INFU United States
- CTNM United States
- Employees
- INFU N/A
- CTNM N/A
- Industry
- INFU Medical/Dental Instruments
- CTNM
- Sector
- INFU Health Care
- CTNM
- Exchange
- INFU Nasdaq
- CTNM Nasdaq
- Market Cap
- INFU 104.4M
- CTNM 122.9M
- IPO Year
- INFU N/A
- CTNM 2024
- Fundamental
- Price
- INFU $6.22
- CTNM $4.76
- Analyst Decision
- INFU
- CTNM Strong Buy
- Analyst Count
- INFU 0
- CTNM 4
- Target Price
- INFU N/A
- CTNM $22.50
- AVG Volume (30 Days)
- INFU 156.0K
- CTNM 128.0K
- Earning Date
- INFU 08-07-2025
- CTNM 08-12-2025
- Dividend Yield
- INFU N/A
- CTNM N/A
- EPS Growth
- INFU 3654.89
- CTNM N/A
- EPS
- INFU 0.15
- CTNM N/A
- Revenue
- INFU $137,582,000.00
- CTNM N/A
- Revenue This Year
- INFU $11.08
- CTNM N/A
- Revenue Next Year
- INFU $8.02
- CTNM N/A
- P/E Ratio
- INFU $41.85
- CTNM N/A
- Revenue Growth
- INFU 7.98
- CTNM N/A
- 52 Week Low
- INFU $4.61
- CTNM $3.35
- 52 Week High
- INFU $9.97
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- INFU 59.27
- CTNM N/A
- Support Level
- INFU $6.09
- CTNM N/A
- Resistance Level
- INFU $6.41
- CTNM N/A
- Average True Range (ATR)
- INFU 0.23
- CTNM 0.00
- MACD
- INFU 0.01
- CTNM 0.00
- Stochastic Oscillator
- INFU 75.64
- CTNM 0.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.